• 1
    Cooper C, Campion G, Melton LJ 1992 Hip fractures in the elderly; a world-wide projection. Osteoporos Int 2:285289.
  • 2
    Ray NF, Chan JK, Thamer M, Melton LJ 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12:2435.
  • 3
    Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:15351541.
  • 4
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. JAMA 282:637645.
  • 5
    Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282:13441352.
  • 6
    McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster J-Y 2001 Effect of risedronate treatment on hip fracture risk in elderly women. N Engl J Med 344:333340.
  • 7
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of recombinant human parathyroid hormone (1–34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med 344:14341441.
  • 8
    Baran DT, Faulkner KG, Genant HK, Miller PD, Pacifici R 1997 Diagnosis and management of osteoporosis: Guidelines for the ultilization of bone densitometry. Calcif Tissue Int 61:433440.
  • 9
    Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D on behalf of the European Foundation for Osteoporosis and Bone Disease 1997 Guidelines for diagnosis and treatment of osteoporosis. Osteoporos Int 7:390406.
  • 10
    Royal College of Physicians 1999 Osteoporosis: Clinical Guidelines for Prevention and Treatment. Royal College of Physicians, London, UK.
  • 11
    World Health Organization 1994 WHO Technical Report Series 843. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. World Health Organization, Geneva, Switzerland.
  • 12
    National Osteoporosis Society 2002 Position Statement on the Reporting of Dual X-Ray Absorptiometry (DXA) Bone Mineral Density Scans. National Osteoporosis Society, Bath, UK.
  • 13
    Faulkner KG, Von Stetton E, Miller P 1999 Discordance in patient classification using T-scores. J Clin Densitom 2:343350.
  • 14
    Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR 1991 Which fractures are associated with low appendicular bone mass in elderly women? Ann Intern Med 115:837842.
  • 15
    Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palmero L, Scott J, Vogt TM 1993 Bone density at various sites for prediction of hip fractures. Lancet 341:7275.
  • 16
    Marshall D, Johnell O, Wedel H 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:12541259.
  • 17
    Altman DG 1991 Practical Statistics for Medical Research. Chapman Hall, London, UK, pp. 409418.
  • 18
    Blake GM, Fogelman I 2001 Peripheral or central densitometry: Does it matter which technique we use? J Clin Densitom 4:8396.
  • 19
    Frost ML, Blake GM, Fogelman I 2001 Does the combination of quantitative ultrasound and dual energy x-ray absorptiometry improve fracture discrimination? Osteoporos Int 12:471477.
  • 20
    Knapp KM, Blake GM, Spector TD, Fogelman I 2001 Multisite quantitative ultrasound: Precision, age- and menopause-related changes, fracture discrimination and T-score equivalence with dual-energy X-ray absorptiometry. Osteoporos Int 12:456464.
  • 21
    Trumpler RJ, Weaver HF 1962 Statistical Astronomy. Dover Publications, New York, NY, USA, pp. 4268.
  • 22
    Altman DG 1991 Practical Statistics for Medical Research. Chapman Hall, London, UK, USA, pp. 277282.
  • 23
    Knapp KM, Blake GM, Fogelman I, Doyle DV, Spector TD 2002 Multisite quantitative ultrasound: Colles fracture discrimination in postmenopausal women. Osteoporos Int 13:474479.
  • 24
    Hui SL, Slemenda CW, Carey MA, Johnston CC 1995 Choosing between predictors of fractures. J Bone Miner Res 10:18161822.
  • 25
    Stegman MR, Recker RR, Davies KM, Ryan RA, Heaney RP 1992 Fracture risk as determined by prospective and retrospective study designs. Osteoporos Int 2:290297.
  • 26
    Zhang J, Yu KF 1998 What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:16901691.
  • 27
    Svendsen OL, Hassager C, Skodt V, Christiansen C 1995 Impact of soft tissue on in-vivo accuracy of bone mineral measurements in the spine, hip and forearm: A human cadaver study. J Bone Miner Res 10:868873.
  • 28
    Grampp S, Genant HK, Mathur A, Lang P, Jergas M, Takada M, Gluer C-C, Lu Y, Chavez M 1997 Comparisons of non-invasive bone mineral measurements in assessing age-related bone loss, fracture discrimination and diagnostic classification. J Bone Miner Res 12:697711.
  • 29
    Mazess RB, Nord RH, Hanson JA, Barden HS 2000 Bilateral measurements of femoral bone mineral density. J Clin Densitom 3:133140.
  • 30
    Genant HK, Lu Y, Mathur AK, Fuerst TP, Cummings SR 1996 Classification based on DXA measurements for assessing the risk of hip fractures. J Bone Miner Res 11:S1;S120.